The head of German conglomerate Bayer has launched a scathing attack on the US legal system, claiming that companies operating in America are preyed on by litigation lawyers and at risk from juries required to rule on complex issues.
Bayer is embroiled in a lengthy legal battle in the US stemming from its $63bn acquisition in 2016 of seedmaker Monsanto, a controversial deal that has left the German group exposed to litigation over an allegedly cancerous weedkiller Roundup.
Since the Monsanto acquisition, which was resisted by some shareholders, Bayer has been pursued through the US courts by thousands of claimants alleging their use of the weedkiller left them with cancer.